Prevention and treatment of adverse effects of corticosteroids in systemic lupus erythematosus

Bailliere's Clinical Rheumatology

Volumn 12, Issue 3, 1998, Pages 495-510

  Ginzler, E M ^a   Aranow, C ^a  

^a SUNY DOWNSTATE MEDICAL CENTER   (United States)

Author keywords

Avascular necrosis; Corticosteroids; Infection; Osteoporosis; Peptic ulcer disease; Steroid toxicity

Indexed keywords

CORTICOSTEROID; NONSTEROID ANTIINFLAMMATORY AGENT;

ARTICLE; ATHEROSCLEROSIS; AVASCULAR NECROSIS; CENTRAL NERVOUS SYSTEM DISEASE; DIABETES MELLITUS; DISEASE ACTIVITY; DYSLIPOPROTEINEMIA; EYE DISEASE; GLUCOSE INTOLERANCE; HUMAN; HYPERTENSION; INFECTION; NONHUMAN; OSTEOPOROSIS; PEPTIC ULCER; PRIORITY JOURNAL; SYSTEMIC LUPUS ERYTHEMATOSUS; WOUND HEALING;

EID: 0031767834     PISSN: 09503579     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0950-3579(98)80032-0     Document Type: Article

References (102)

1. Adachi JD Bensen WG Brown J Intermittent etidronate therapy to prevent corticosteroid-induced osteoporosis New England Journal of Medicine 337 1997 382 387
2. Aranow C Zelicof S Leslie D Clinically occult avascular necrosis of the hip in systemic lupus erythematosus Journal of Rheumatology 24 1997 2318 2322
3. Askari A Vignos PJ Moslowitz RW Steroid myopathy in connective tissue disease American Journal of Medicine 61 1976 485 492
4. Becker B Cataracts and topical corticosteroids American Journal of Ophthalmology 58 1964 872 873
5. Borba EF Bonfà E Dyslipoproteinemias in systemic lupus erythematosus: influence of disease, activity, and anticardiolipin antibodies Lupus 6 1997 533 539
6. Boumpas DT Paliogianni F Anastassiou ED Glucocorticosteroid action on the immune system: molecular and cellular aspects Clinical and Experimental Rheumatology 9 1991 413 423
7. Boyer MH Hyperosmolar anacidotic coma in association with glucocorticoid therapy Journal of the American Medical Association 202 1967 1007 1009
8. (Abstract) Bruce IN Burns RJ Gladman DD Factors associated with myocardial perfusion abnormalities in women with SLE Arthritis and Rheumatism 40 1997 S302
9. Budman DR Steinberg AD Hypertension and renal disease in systemic lupus erythematosus Archives of Internal Medicine 136 1976 1003 1007
10. Bulkley BH Roberts WC The heart in systemic lupus erythematosus and the changes induced in it by corticosteroid therapy. A study of 36 necropsy patients American Journal of Medicine 58 1975 243 264
11. Burns TW Cushing's syndrome Sodeman WA Jr Sodeman TM Pathologic Physiology. Mechanisms of Disease 6th edn. 1979 W.B. Saunders Co. Philadelphia 1002 1105
12. Buyon JP Kalunian KC Skovron ML Can women with systemic lupus erythematosus safely use exogenous estrogens? Journal of Clinical Rheumatology 1 1995 205 212
13. Chambless LE Heiss G Folsom AR Association of coronary heart disease incidence with carotid arterial wall thickness and major risk factors: the Athrosclerosis Risk in Communities (ARIC) study American Journal of Epidemiology 146 1997 483 494
14. Chan AC Sack K Danazol therapy in autoimmune hemolytic anemia associated with systemic lupus erythematosus Journal of Rheumatology 18 1991 280 282
15. Conn HO Blitzer BL Nonassociation of adrenocorticosteroid therapy and peptic ulcer New England Journal of Medicine 2954 1976 473 479
16. Conn HO Poynard T Corticosteroids and peptic ulcer: meta-analysis of adverse events during steroid therapy Journal of Internal Medicine 236 1994 619 632
17. Cordess C Folstein M Drachman D Psychiatric effects of alternate day steroid therapy British Journal of Psychiatry 138 1981 504 506
18. Cumming RG Mitchell P Leeder SR Use of inhaled corticosteroids and the risk of cataracts New England Journal of Medicine 337 1997 46 48
19. Dhillon VB Davies MC Hall ML Assessment of the effect of oral corticosteroids on bone mineral density in systemic lupus erythematosus: a preliminary study with dual energy x ray absorptiometry Annals of the Rheumatic Diseases 49 1990 624 626
20. Dimant J Ginzler EM Diamond HS Computer analysis of factors influencing the appearance of aseptic necrosis in patients with SLE Journal of Rheumatology 5 1978 136 141
21. Dostal GH Gamelli RL The differential effect of corticosteroids on wound disruption strength in mice Archives of Surgery 125 1990 636 640
22. Dubois EL Prednisone and prednisolone in the treatment of systemic lupus erythematosus Journal of the American Medical Association 161 1956 427 433
23. Ettinger WH Goldberg AP Applebaum-Bowden D Dyslipoproteinemia in systemic lupus erythematosus. Effects of corticosteroids American Journal of Medicine 83 1987 503 508
24. Felson DT Anderson J Evidence for the superiority of immunosuppressive drugs and prednisone over prednisone alone in lupus nephritis New England Journal of Medicine 311 1984 1528 1533
25. Fink SD Kremer JM Successful treatment of interstitial lung disease in systemic lupus erythematosus with methotrexate Journal of Rheumatology 22 1995 967 969
26. Formiga F Moga I Nolla JM Loss of bone mineral density in premenopausal women with systemic lupus erythematosus Annals of the Rheumatic Diseases 54 1995 274 276
27. Formiga Perez F Moga Sampere I Canet Gonzalez R Infection and systemic lupus erythematosus: analysis of a series of 145 patients Revista Clinica Espanola 193 1993 105 109
28. Friedman M Bosch JV Byers SO Effect of cortisone on lipid and cholesterol metabolism in the rabbit and rat American Journal of Physiology 208 1965 94 105
29. Furie RA Chartash EK Tendon rupture in systemic lupus erythematosus Seminars in Arthritis and Rheumatism 18 1988 127 133
30. Gennari R Alexander JW Arginine, glutamine, and dehydroepiandrosterone reverse the immunosuppressive effect of prednisone during gut-derived sepsis Critical Care Medicine 25 1997 1207 1214
31. Ginzler E Sharon E Diamond H Long-term maintenance therapy with azathioprine in systemic lupus erythematosus Arthritis and Rheumatism 18 1975 27 34
32. Ginzler E Diamond H Kaplan D Computer analysis of factors influencing frequency of infection in systemic lupus erythematosus Arthritis and Rheumatism 21 1978 37 44
33. Gladman DD Urowitz MB Morbidity in systemic lupus erythematosus Journal of Rheumatology 14 supplement 13 1987 223 226
34. (letter) Glynne-Jones R Vernon CC Bell G Is steroid psychosis preventable by divided doses? Lancet ii 1986 1404
35. Graham DY White RH Morland LW Duodenal and gastric ulcer prevention with misoprostol in arthritis patients taking NSAIDs Annals of Internal Medicine 119 1993 257 262
36. Haider YS Roberts WC Coronary arterial disease in systemic lupus erythematosus. Quantification of degrees of narrowing in 22 necropsy patients (21 women) aged 16 to 37 years American Journal of Medicine 70 1981 775 781
37. Hashimoto M Nonaka S Furuta E Methotrexate for steroid-resistant systemic lupus erythematosus Clinical Rheumatology 13 1994 280 283
38. (Abstract) Hepburn B Furie R Cash J Reduction of anti-dsDNA antibodies using LJP394 in patients with lupus Arthritis and Rheumatism 39 1996 S307
39. Hesselink VJ Luijendijk RW de Wilt JHW An evaluation of risk factors in incisional hernia recurrence Surgery, Gynecology and Obstetrics 176 1993 228 234
40. Hodis HN Quismorio FP Jr Wickham E The lipid, lipoprotein, and apolipoprotein effects of hydroxchloroquine in patients with systemic lupus erythematosus Journal of Rheumatology 20 1993 661 665
41. Hosenpud JD Montanaro A Hart MV Myocardial perfusion abnormalities in asymptomatic patients with systemic lupus erythematosus American Journal of Medicine 77 1984 286 292
42. Ilowite NT Ginzler E Jacobson MS Dyslipoproteinemia in pediatric systemic lupus erythematosus Arthritis and Rheumatism 31 1988 859 863
43. Ilowite NT Copperman N Leicht T Effects of dietary modification and fish oil supplementation on dyslipoproteinemia in pediatric systemic lupus erythematosus Journal of Rheumatology 22 1995 1347 1351
44. Kalla AA Fataar AB Jessop SJ Loss of trabecular bone mineral density in systemic lupus erythematosus Arthritis and Rheumatism 36 1993 1726 1734
45. Kanayama Y Shiota K Horiguchi T Correlation between steroid myopathy and serum lactic dehydrogenase in systemic lupus erythematosus Archives of Internal Medicine 141 1981 1176 1179
46. Keystone EC Strand V Biologic agents in autoimmune disease Journal of Rheumatology 23 1996 743 746
47. Kipen Y Buchbinder R Forbes A Prevalence of reduced bone mineral density in systemic lupus erythematosus and the role of steroids Journal of Rheumatology 24 1997 1922 1929
48. Kojima M Shui YB Murano H Inhibition of steroid-induced cataract in rat eyes by administration of vitamin-E ophthalmic solution Ophthalmic Research 28 supplement 2 1996 64 71
49. Lance NJ Blaszak W Swartz TJ Bullous skin lesions in systemic lupus erythematosus Seminars in Arthritis and Rheumatism 20 1991 396 404
50. Lane NE Mroczkowski PJ Hochberg MC Prevention and management of glucocorticoid-induced osteoporosis Bulletin on the Rheumatic Diseases 44 5 1995 1 4
51. Leong KH Koh ET Feng PH Lipid profiles in patients with systemic lupus erythematosus Journal of Rheumatology 21 1994 1264 1267
52. McMurray RW Weidensaul D Allen SH Efficacy of bromocriptine in an open label trial for systemic lupus erythematosus Journal of Rheumatology 22 1995 2084 2091
53. Massardo L Jacobelli S Leissner M High-dose intravenous methylprednisolone therapy associated with osteonecrosis in patients with systemic lupus erythematosus Lupus 1 1992 401 405
54. Meller J Conde CA Deppish LM Myocardial infarction due to coronary atherosclerosis in three young adults with systemic lupus erythematosus American Journal of Cardiology 35 1975 309 314
55. Messer J Reitman D Sacks HS Association of adrenocorticosteroid therapy and peptic ulcer disease New England Journal of Medicine 309 1983 21 24
56. Migliaresi S Picillo U Ambrosone L Avascular osteonecrosis in patients with SLE: relation to corticosteroid therapy and anticardiolipin antibodies Lupus 3 1994 37 41
57. Mont MA Glueck CJ Pacheco IH Risk factors for osteonecrosis in systemic lupus erythematosus Journal of Rheumatology 24 1997 654 662
58. Nayak J Esdaile JM The efficacy of antimalarials in systemic lupus erythematosus Lupus 5 supplement 1 1996 S23 S27
59. Niwa Y Iizawa O Abnormalities in serum lipids and leukocyte superoxide dismutase and associated cataract formation in patients with atopic dermatitis Archives of Dermatology 130 1994 1387 1392
60. Olefsky J Kimmerling G Effects of glucocorticoids on carbohydrate metabolism American Journal of the Medical Sciences 271 1976 202 210
61. Paulino-Netto A Dreiling D Pancreatitis in disseminated lupus erythematosus Journal of Mount Sinai Hospital 27 1960 291 295
62. Petri M Musculoskeletal complications of systemic lupus erythematosus in the Hopkins Lupus Cohort: an update Arthritis Care and Research 8 1995 137 145
63. (Abstract) Petri M Hamper U Frequency of atherosclerosis detected by carotid duplex in SLE Arthritis and Rheumatism 40 1997 219
64. Petri M Perez-Gutthann S Spence D Risk factors for coronary artery disease in patients with systemic lupus erythematosus American Journal of Medicine 93 1992 513 519
65. Petri M Lakatta C Magder L Effect of prednisone and hydroxychloroquine on coronary artery disease risk factors in systemic lupus erythematosus: a longitudinal data analysis American Journal of Medicine 96 1994 254 259
66. Phillips JD Kim CS Fonkalsrud EW Effects of chronic corticosteroids and vitamin A on the healing of intestinal anastomoses American Journal of Surgery 163 1992 71 77
67. Piper JM Ray WA Daugherty JR Corticosteroid use and peptic ulcer disease. Role of antiinflammatory drugs Annals of Internal Medicine 114 1991 735 740
68. Pistiner M Wallace DJ Nessim S Lupus erythematosus in the 1980s: a survey of 570 patients Seminars in Arthritis and Rheumatism 21 1991 55 64
69. Pons F Peris P Guañabens N The effect of systemic lupus erythematosus and long-term steroid therapy on bone mass in premenopausal women British Journal of Rheumatology 34 1995 742 746
70. Pritchard CH Berney S Patellar tendon rupture in systemic lupus erythematosus Journal of Rheumatology 16 1989 786 788
71. Punch JD Shieck VL Campbell DA Jr Corticosteroid withdrawal after liver transplantation Surgery 118 1995 783 788
72. Rahman P Bruce IN Chung M Effect of antimalarials on serum cholesterol in SLE Arthritis and Rheumatism 40 1997 S303
73. Renfro L Snow JS Ocular effects of topical and systemic steroids Dermatologic Clinics 10 1992 505 512
74. (Abstract) Ritchlin C Dobro J Senie R Opportunistic infections in patients with systemic lupus erythematosus Arthritis and Rheumatism 32 supplement 1989 S115
75. Rosner S Ginzler EM Diamond HS A multicenter study of outcome in systemic lupus erythematosus. II. Causes of death Arthritis and Rheumatism 25 1982 612 617
76. Saab S Corr MP Weisman MH Corticosteroids and systemic lupus erythematosus pancreatitis: case series and review of the literature Journal of Rheumatology 25 1998 801 808
77. Schäfers HJ Wagner TOF Demertzis S Preoperative corticosteroids. A contra-indication to lung transplantation? Chest 102 1992 1522 1525
78. Smith CL Corticosteroid glaucoma: a summary and review of the literature American Journal of the Medical Sciences 252 1966 239
79. Soffer IJ Bader R Corticotropin and cortisone in acute disseminated lupus erythematosus: results of long term use Journal of the American Medical Association 149 1952 1002 1008
80. Staples PJ Gerding DN Decker JL Incidence of infection in systemic lupus erythematosus Arthritis and Rheumatism 17 1974 1 10
81. Stern MP Koterman OG Fries JF Adrenocortical steroid treatment of rheumatic diseases—effects on lipid metabolism Archives of Internal Medicine 132 1973 97 101
82. Sudhir K Jennings GL Esler MD Hydrocortisone-induced hypertension in humans: pressor responsiveness and sympathetic function Hypertension 13 1989 416 421
83. Sultan H Berson J Mirotznik J Lack of evidence for corticosteroids as a risk factor for coronary artery disease in systemic lupus erythematosus Paper presented at the Northeast Region American College of Rheumatology meeting New York, June 1994 1994
84. Taskinen MR Kuusi T Yki-Jarvinen H Short-term effects of prednisone on serum lipids and high density lipoprotein subfractions in normolipidemic healthy men Journal of Clinical Endocrinology and Metabolism 67 1988 291 299
85. Thomas JW Vertkin A Nell LJ Antiinsulin antibodies and clinical characteristics of patients with systemic lupus erythematosus and other connective tissue diseases with steroid induced diabetes Journal of Rheumatology 14 1987 732 735
86. Tincani A Brey R Balestrieri B International survey on the management of patients with SLE. II. The results of a questionnaire regarding neuropsychiatric manifestations Clinical and Experimental Rheumatology 14 supplement 16 1996 S23 S29
87. Tsakraklides VG Blieden LC Edwards JE Coronary atherosclerosis and myocardial infarction with systemic lupus erythematosus American Heart Journal 87 1974 637 641
88. Urowitz MB Bookman ASM Koehler BE The bimodal mortality pattern of systemic lupus erythematosus American Journal of Medicine 60 1976 221 225
89. van Vollenhoven RF Englemand EG McGuire JL Dehydroepiandrosterone in systemic lupus erythematosus. Results of a double-blind, placebo-controlled, randomized clinical trial Arthritis and Rheumatism 38 1995 1826 1831
90. Wallace DJ Metzger AL Stecher VJ Cholesterol lowering effect of hydroxychloroquine in patients with rheumatic disease: reversal of deleterious effects of steroids on lipids American Journal of Medicine 89 1990 322 326
91. Walton AJE Snaith ML Locniskar M Dietary fish oil and the severity of symptoms in patients with systemic lupus erythematosus Annals of the Rheumatic Diseases 50 1991 463 466
92. Wang GJ Sweet DE Reger SI Fat-cell changes as a mechanism of avascular necrosis of the femoral head in cortisone-treated rabbits Journal of Bone and Joint Surgery (American) 59 1977 729 735
93. Watanabe Duffy KN Duffy CM Gladman DD Infection and disease activity in SLE: a review of hospitalized patients Journal of Rheumatology 18 1991 1180 1184
94. Weiner ES Abeles M Aseptic necrosis and glucocorticosteroids in systemic lupus erythematosus: a reevaluation Journal of Rheumatology 16 1989 604 608
95. Weinstock-Guttman B Nair D Cohen JA Neurologic complications of immunosuppressive and anti-inflammatory therapy for rheumatic diseases Journal of Clinical Rheumatology 2 1996 268 278
96. Werth VP Glucocorticoid-induced osteoporosis. Evaluation, prevention, and treatment Journal of Clinical Rheumatology 3 1997 S69 S73
97. West SG Johnson SC Danazol for the treatment of refractory autoimmune thrombocytopenia in systemic lupus erythematosus Annals of Internal Medicine 108 1988 703 706
98. Wilke WS Krall PL Scheetz RJ Methotrexate for systemic lupus erythematosus: a retrospective analysis of 17 unselected cases Clinical and Experimental Rheumatology 9 1991 581 587
99. Wilson K Abeles M A 2 year, open ended trial of methotrexate in systemic lupus erythematosus Journal of Rheumatology 21 1994 1674 1677
100. Zhou M Quing J Liu Z Using a lipid clearing drug to prevent osteocytes damage of the femoral head in steroid-treated rabbits Chinese Medical Journal 76 1996 13 16
101. Zimmerman J Fainaru M Eisenberg S The effect of prednisone therapy on plasma lipoproteins and apolipoproteins; a prospective study Metabolism 33 1984 521 526
102. Zizic TM Marcoux C Hungerford DS Corticosteroid therapy associated with ischemic necrosis of bone in systemic lupus erythematosus American Journal of Medicine 79 1985 596 604